Lates News

According to sources, the Trump administration is set to impose tariffs on pharmaceutical companies that have not yet reached agreements to ensure low-price sales in the United States, starting as early as Thursday local time. This is the latest move in imposing import taxes on the grounds of national security. Over the past year, Trump has been threatening to impose tariffs on the pharmaceutical industry, with rates possibly between 100% to 200%, in order to force pharmaceutical companies to move manufacturing back to the United States and lower drug prices for American patients. Most major pharmaceutical companies, including Pfizer and Eli Lilly, have already reached agreements with the White House to exempt them from these tariffs for a period of three years. Sources say that the new tariffs stem from an investigation conducted under the Section 232 of the Trade Expansion Act of 1962. Companies that have not reached agreements and have not negotiated with the government will face a 100% tariff. Sources say the plan is not yet finalized and may still change. They also mentioned that certain drugs and categories of diseases may also be exempted.